GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedAvail Holdings Inc (STU:73M) » Definitions » ROE % Adjusted to Book Value

MedAvail Holdings (STU:73M) ROE % Adjusted to Book Value : -246.26% (As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is MedAvail Holdings ROE % Adjusted to Book Value?

MedAvail Holdings's ROE % for the quarter that ended in Jun. 2023 was -169.92%. MedAvail Holdings's PB Ratio for the quarter that ended in Jun. 2023 was 0.69. MedAvail Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was -246.26%.


MedAvail Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for MedAvail Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedAvail Holdings ROE % Adjusted to Book Value Chart

MedAvail Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22
ROE % Adjusted to Book Value
- - - -241.23

MedAvail Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -72.15 -78.10 -159.84 -105.53 -246.26

Competitive Comparison of MedAvail Holdings's ROE % Adjusted to Book Value

For the Pharmaceutical Retailers subindustry, MedAvail Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedAvail Holdings's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedAvail Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where MedAvail Holdings's ROE % Adjusted to Book Value falls into.



MedAvail Holdings ROE % Adjusted to Book Value Calculation

MedAvail Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-246.05% / 1.02
=-241.23%

MedAvail Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-169.92% / 0.69
=-246.26%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedAvail Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of MedAvail Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


MedAvail Holdings (STU:73M) Business Description

Traded in Other Exchanges
Address
4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040
MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.

MedAvail Holdings (STU:73M) Headlines

No Headlines